SCHEMBL30459674

SCHEMBL30459674

Nc1ccc(N2CCN(Cc3ccc4c(c3)CN(C3CCCNC3)C4=O)CC2)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2B P41595 4/20 0.39
▸ HTR2A P28223 3/20 0.39
▸ HTR2C P28335 3/20 0.39
▸ PARP1 P09874 7/20 0.37
▸ CRBN Q96SW2 1/20 0.36
▸ IKZF3 Q9UKT9 1/20 0.36
▸ IKZF2 Q9UKS7 5/20 0.36
▸ TNK2 Q07912 1/20 0.35
▸ TNK1 Q13470 1/20 0.35
▸ WIZ O95785 1/20 0.35
▸ HTR3E A5X5Y0 1/20 0.35
▸ HTR3B O95264 1/20 0.35
▸ HTR3A P46098 1/20 0.35
▸ TMEM97 Q5BJF2 1/20 0.35
▸ HTR3D Q70Z44 1/20 0.35
▸ HTR3C Q8WXA8 1/20 0.35
▸ BMPR1A P36894 1/20 0.34
▸ ACVRL1 P37023 1/20 0.34
▸ ACVR1 Q04771 1/20 0.34
▸ TNKS O95271 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26110172 0.83 IKZF2 (0.52) HTR2BHTR2AHTR2CPARP1IKZF2
SCHEMBL25270702 0.82 CRBN (0.38) PARP1CRBNIKZF3IKZF2TNKS
SCHEMBL30790468 0.82 HTR2C (0.51) HTR2BHTR2AHTR2CPARP1IKZF2
SCHEMBL30458487 0.82 CRBN (0.42) HTR2BHTR2AHTR2CPARP1CRBN
SCHEMBL30459017 0.81 HTR2C (0.46) HTR2BHTR2AHTR2CPARP1IKZF2
SCHEMBL31076678 0.80 IKZF2 (0.57) CRBNIKZF3IKZF2WIZ
SCHEMBL25647405 0.80 IKZF2 (0.57) CRBNIKZF3IKZF2WIZ
SCHEMBL30458859 0.79 PARP1 (0.46) HTR2BHTR2AHTR2CPARP1TNK2
SCHEMBL30741716 0.78 PARP1 (0.42) HTR2BHTR2AHTR2CPARP1CRBN
SCHEMBL30458379 0.76 HTR2B (0.44) HTR2BHTR2AHTR2CPARP1IKZF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104155-A1 LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF 标新生物医药科技(上海)有限公司 2023-06-15 — — WO claimed
Send feedback